ResMed (RMD) has a market capitalization of $32.3B, based on 140.66M shares at a price of $229.94 (down 6.7% on Friday).
| DATE | CLOSE | VOLUME | OUTSTANDING | MARKET CAP |
|---|---|---|---|---|
October 2026 | $229.94 | 26,943,700 | 140,657,075 | $32,342,687,825.50 |
September 2026 | $221.10 | 26,331,800 | 143,411,000 | $31,708,172,100.00 |
August 2026 | $240.10 | 33,354,900 | 143,411,000 | $34,432,981,100.00 |
July 2026 | $210.38 | 30,521,300 | 143,411,000 | $30,170,275,559.30 |
June 2026 | $194.32 | 33,526,300 | 144,976,000 | $28,172,084,262.40 |
May 2026 | $190.02 | 32,320,400 | 144,976,000 | $27,549,020,907.20 |
April 2026 | $212.57 | 22,216,200 | 144,976,000 | $30,816,982,913.60 |
March 2026 | $223.17 | 23,291,500 | 147,037,000 | $32,814,835,438.00 |
February 2026 | $254.77 | 23,313,800 | 147,037,000 | $37,460,484,156.70 |
January 2026 | $256.21 | 20,444,200 | 147,037,000 | $37,672,893,806.90 |
December 2025 | $238.92 | 20,187,600 | 147,037,000 | $35,129,374,262.40 |
November 2025 | $253.75 | 22,302,800 | 147,037,000 | $37,311,197,490.60 |
October 2025 | $244.30 | 24,558,800 | 147,037,000 | $35,920,462,729.80 |
September 2025 | $270.86 | 19,862,800 | 147,037,000 | $39,827,074,079.10 |
August 2025 | $271.64 | 22,104,500 | 147,037,000 | $39,940,557,235.70 |
July 2025 | $268.53 | 20,771,200 | 147,037,000 | $39,484,286,721.00 |
June 2025 | $254.77 | 15,760,500 | 147,037,000 | $37,460,263,601.20 |
May 2025 | $241.72 | 19,061,000 | 147,037,000 | $35,542,239,454.70 |
April 2025 | $233.12 | 29,995,000 | 147,037,000 | $34,277,236,032.60 |
March 2025 | $220.57 | 19,413,200 | 147,220,000 | $32,471,829,574.00 |
February 2025 | $230.09 | 18,452,200 | 147,220,000 | $33,874,571,178.00 |
January 2025 | $232.19 | 19,355,000 | 147,220,000 | $34,183,689,012.00 |
December 2024 | $224.83 | 15,617,000 | 147,599,000 | $33,184,816,009.10 |
November 2024 | $244.82 | 17,190,400 | 147,599,000 | $36,134,877,222.10 |
October 2024 | $237.86 | 24,483,000 | 147,599,000 | $35,108,503,295.90 |